Lance Han
Founder & PresidentAt Cyagen, we believe in making world-class science more accessible. Through continuous innovation and customer-centered service, we empower researchers to translate ideas into impactful therapies.
Who We Are
Advancing Global Life Science
Founded in 2006, Cyagen is a global life science company specializing in genetically engineered models, preclinical services, and the discovery of proprietary antibody, cell, and gene therapies. Headquartered in Santa Clara, California, we leverage advanced technologies and scientific expertise to drive therapeutic innovation through strategic partnerships.
With more than 1000 employees and research and production facilities spanning over 40,000 m², Cyagen supports academic institutions, biotechnology companies, and pharmaceutical organizations in more than 100 countries and regions as both a trusted CRO service provider and a collaborative discovery partner.
2006Founded
40,000+ m²Research & Production
39,000+Mouse Strains
16,500+SCI Citations
Reza Rezaei, PhD
Chief Executive OfficerOur comprehensive services cover every stage of preclinical research – from design and development to drug screening and efficacy evaluation. We partner with clients to accelerate their scientific breakthroughs.
Our Vision
At Cyagen, our vision is to advance global life science with exceptional models, services, and novel therapeutics. We create infinite possibilities by providing reliable tools, scalable technologies, promising out-licensing candidates, and expert guidance — because at our core, we help you discover life.
How We Evolved
From Innovation to Integrated Research Solutions
Key milestones in Cyagen's development and expanding scientific capabilities.
2006
Foundation
2013
Gene Editing Technology Innovation
Established proprietary ES cell-based TurboKnockout™ gene-targeting technology.
2020
Capacity Expansion
Expanded its research and production facilities in China to over 40,000 m².
2026
HUGO-LAb
Launched HUGO-LAb™, a modular fully human antibody library for rapid assembly.
What We Do
Integrated Solutions Across the Research Journey
Research Models
Customized and ready-to-use genetically engineered rodent models for diverse biomedical research applications.
Gene Editing
Advanced gene-editing technologies for complex genetically modified animal models and engineered cell lines.
Preclinical Research
Model generation, in vivo and in vitro pharmacology, efficacy evaluation, and mechanism-of-action studies.
Antibody Discovery Platforms
Advanced antibody discovery and cell-engineering platforms supporting emerging therapeutic research.
From Discovery
to Translation
to Translation
Gene Editing
Antibody Discovery
Preclinical Research
Virus Packaging
Research Models
Our Capabilities
Connecting Science, Technology & Translational Research
Cyagen brings together advanced technologies, research models, and scientific expertise across the research lifecycle.
Antibody DiscoveryTherapeutic antibody research platforms
Gene EditingAdvanced genetic engineering platforms
Model GenerationCustom and standardized research models
AAV PlatformAAV production and delivery platforms
Cell EngineeringiPSC & Engineered Cell Platforms
Preclinical ResearchDrug efficacy and mechanism studies
Our Global Presence
Global Network for Scientific Discovery
With a growing global footprint, Cyagen connects scientific teams and research facilities across the United States, China, and Japan. Anchored by its Santa Clara headquarters and operations in Guangzhou, Suzhou, and Gu'an, Cyagen delivers scientific support to researchers and organizations in more than 100 countries and regions.
100+Countries & Regions Served
10,700+Global Research Partners
Who We Partner With
Collaborating Across the Scientific Community
Cyagen works with academic institutions, biotechnology companies, and pharmaceutical organizations to support biomedical discovery and drug development.
Leading Pharma CompaniesSupporting preclinical and translational research programs
Academic InstitutionsEmpowering basic research and model development
Biotechnology CompaniesAccelerating discovery from concept to clinic
Research CollaboratorsCo-developing platforms, publications, and tools
Our Quality and Compliance
Building Trust Through Quality & Certification
From animal care and research standards to quality management, Cyagen follows internationally recognized standards, reflected in its AAALAC accreditation and ISO 9001 certification.
AAALAC Accreditation – Guangzhou
AAALAC Accreditation – Suzhou
AAALAC Accreditation – Gu'an
ISO 9001 Certification – Cyagen
ISO 9001 Certification – Guangzhou
ISO 9001 Certification – Suzhou
ISO 9001 Certification – Gu'an
OLAW Assurance
ISO 27001 Information Security
Check Out The Latest
Cyagen and Tsinghua Research Team Develop PPBind-3D/1D AI Framework for Protein–Protein Binding Affinity Prediction
November 02, 2026
View Details
Accelerating the Path to IND: Cyagen Empowers Global Biopharma with Integrated Preclinical CRO Solutions
September 08, 2026
View Details
Cyagen's ProF Humanized Mouse Platform Supports FDA IND Clearance for Chimigen's Cancer Immunotherapy
July 28, 2026
View Details
Cyagen Biosciences and Research Partners Announce AI-Engineered AAV Platform for Next-Generation Retinal Gene Therapy
July 14, 2026
View Details